All In Biotech

Drug Trial Radar · NCT04124926

Efficacy and Safety of Vonoprazan Compared to Lansoprazole in Participants With Erosive Esophagitis

A Phase 3, Randomized, Double-Blind, Two Phase, Multicenter Study to Evaluate the Efficacy and Safety of Vonoprazan 20 mg Compared to Lansoprazole 30 mg for Healing in Patients With Erosive Esophagitis and to Evaluate the Efficacy and Safety of Vonoprazan (10 mg and 20 mg) Compared to Lansoprazole 15 mg for the Maintenance of Healing in Patients With Healed Erosive Esophagitis

Last checked: Nov 19, 2026Latest source record: Jul 29, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 1,027 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,027

Actual

Start

Oct 28, 2019

Primary completion

Jul 29, 2021

Study completion Aug 24, 2021

Sponsor

Lead sponsor
Phathom Pharmaceuticals, Inc.Industry
Sponsor type
Industry
First posted
Oct 14, 2019

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To evaluate the efficacy and safety of vonoprazan compared to lansoprazole in participants with erosive esophagitis.

Conditions

  • Erosive Esophagitis

Interventions

  • VonoprazanDrug

    Over-encapsulated tablet administered orally with approximately 240 mL water, 30 minutes prior to the morning meal.

  • LansoprazoleDrug

    Over-encapsulated capsule administered orally with approximately 240 mL water, 30 minutes prior to the morning meal.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Healing Phase: Percentage of Participants Who Had Complete Healing of EE by Week 8Time frame: Week 8
  2. Maintenance Phase: Percentage of Participants Who Maintained Complete Healing of EE at Week 24Time frame: Week 24

Locations

157 sites in 6 countries. Site status is shown where the registry gives one.

  • Pinnacle Research Group

    Anniston, Alabama

  • North Alabama Research Center LLC

    Athens, Alabama

  • Synexus Clinical Research US, Inc.

    Birmingham, Alabama

  • Medical Affiliated Research Center Inc

    Huntsville, Alabama

  • Synexus Clinical Research US, Inc. - East Valley Family Physicians, PLC

    Chandler, Arizona

  • Synexus Clinical Research US, Inc. - Central Arizona Medical Associates, PC

    Mesa, Arizona

  • Synexus Clinical Research US, Inc. - Desert Clinical Research, LLC

    Mesa, Arizona

  • Elite Clinical Studies - Phoenix - BTC - PPDS

    Phoenix, Arizona

  • Hope Research Institute LLC

    Phoenix, Arizona

  • Del Sol Research Management - BTC - PPDS

    Tucson, Arizona

  • Preferred Research Partners - ClinEdge - PPDS

    Little Rock, Arkansas

  • Applied Research Center of Little Rock

    Little Rock, Arkansas

  • Arkansas Gastroenterology

    North Little Rock, Arkansas

  • Atria Clinical Research - BTC - PPDS

    North Little Rock, Arkansas

  • Anaheim Clinical Trials LLC

    Anaheim, California

  • GW Research, Inc. - ClinEdge - PPDS

    Chula Vista, California

  • eStudySite - Chula Vista - PPDS

    Chula Vista, California

  • Kindred Medical Institute for Clinical Trials, LLC

    Corona, California

  • HB Clinical Trials, Inc.

    Fountain Valley, California

  • OM Research LLC

    Lancaster, California

  • Torrance Clinical Research Institute

    Lomita, California

  • LA County + USC Medical Center

    Los Angeles, California

  • Southern California Research Institute Medical Group, Inc.

    Los Angeles, California

  • Facey Medical Foundation

    Mission Hills, California

  • Palmtree Clinical Research

    Palm Springs, California

  • Precision Research Institute

    San Diego, California

  • Medical Associates Research Group, Inc.

    San Diego, California

  • Paragon Rx Clinical, Inc.

    Santa Ana, California

  • Synexus Clinical Research US, Inc. - Colorado Springs Family Practice

    Colorado Springs, Colorado

  • Western States Clinical Research, Inc.

    Wheat Ridge, Colorado

  • Gastroenterology Associates of Fairfield County

    Bridgeport, Connecticut

  • Connecticut Clinical Research Foundation

    Bristol, Connecticut

  • Riverside Clinical Research

    Edgewater, Florida

  • Research Centers of America - ERG

    Hollywood, Florida

  • Nature Coast Clinical Research

    Inverness, Florida

  • ENCORE Borland-Groover Clinical Research - ERN - PPDS

    Jacksonville, Florida

  • Columbus Clinical Services LLC

    Miami, Florida

  • Jesscan Medical Research

    Miami, Florida

  • Nuren Medical and Research Center

    Miami, Florida

  • Premier Research Associate, Inc.

    Miami, Florida

Showing 40 of 157 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.